DailyStocks Stock Article Search

https://www.cnbc.com/2024/02/06/healthy-returns-novo-nordisk-eli-lilly-tackle-weight-loss-drug-supply-woes.html Feb 06, 2024 - Novo Nordisk and Eli Lilly are working to increase supply of their popular weight loss drugs. Meanwhile, the implantable neurotechnology field is heating up. 0

https://www.cnbc.com/2024/02/06/eli-lilly-weight-loss-drug-may-treat-fatty-liver-disease.html Feb 06, 2024 - The results add to a long list of potential health benefits of tirzepatide besides helping patients shed significant pounds and regulate blood sugar. 0

https://seekingalpha.com/news/4063338-nash-drug-developers-drop-trial-win-lilly-drug?source=feed_sector_healthcare Feb 06, 2024 - Companies focused on NASH drugs drop as Eli Lilly's (LLY) weight loss drug, tirzepatide, hits main goal in a mid-stage trial for the liver disease. Read more here. 0

https://www.zacks.com/commentary/2220146/top-stock-reports-for-eli-lilly-danaher-citigroup?cid=CS-ZC-FT-research_daily-2220146 Feb 02, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR) and Citigroup Inc. (C). 0

https://seekingalpha.com/news/4058092-eli-lilly-gene-therapy-restores-hearing-phase-12-trial?source=feed_sector_healthcare Jan 24, 2024 - Eli Lilly's (LLY) gene therapy candidate, AK-OTOF, successfully restored hearing in an 11-year-old boy with congenital hearing loss. Read more here. 0

https://seekingalpha.com/news/4056131-eli-lilly-jaypirca-lead-btk-inhibitor-market-leukemia?source=feed_sector_healthcare Jan 18, 2024 - Eli Lilly&amp;#39;s (LLY) cancer drug, Jaypirca, is expected to dominate the market for BTK inhibitors for chronic lymphocytic leukemia in seven major markets. Read more here. 0

https://www.zacks.com/commentary/2211986/top-analyst-reports-for-eli-lilly-linde-nextera-energy?cid=CS-ZC-FT-research_daily-2211986 Jan 18, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and NextEra Energy, Inc. (NEE). 0

https://www.zacks.com/commentary/2204956/top-research-reports-for-amazon-com-berkshire-hathaway-eli-lilly?cid=CS-ZC-FT-research_daily-2204956 Jan 03, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Berkshire Hathaway Inc. (BRK.B) and Eli Lilly and Company (LLY). 0

https://www.fool.com/investing/2024/01/03/missed-out-eli-lilly-best-pharmaceutical-stock/?source=iedfolrf0000001 Jan 03, 2024 - The past three years were bliss for Eli Lilly shareholders, but those not already on board should look at its rival instead. 0

https://www.fool.com/investing/2023/12/31/eli-lilly-stock-jumped-59-in-2023-is-it-a-good-sto/?source=iedfolrf0000001 Dec 31, 2023 - Sales of its new weight-management drug could be off the charts next year. 0